fluorodeoxyglucose f18 has been researched along with mitomycin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaizawa, T; Fukuda, H; Ido, T; Kanamaru, R; Maeda, S; Oikawa, H; Takahashi, H; Yoshioka, T | 1 |
| Hashimoto, D; Hoshino, T; Ishida, H; Nakada, H; Ohsawa, T; Okada, N; Ozawa, F; Takeuchi, I; Yokoyama, M | 1 |
| Endo, K; Higuchi, T; Inoue, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Jeong, HJ; Kim, DW; Lim, ST; Sohn, MH; Yim, CY | 1 |
| Cohen, SJ; Konski, A; Li, T; Meropol, NJ; Sigurdson, E; Small, W; Spies, S; Stryker, S; Wahl, A; Yu, JQ | 1 |
| Heriot, A; Leong, T; Ngan, SY; Wang, ML | 1 |
| Baccega, M; Bellò, M; Cassoni, P; Cravero, F; Filippini, C; Fora, G; Lesca, A; Milanesi, E; Mistrangelo, M; Morino, M; Munoz, FH; Pelosi, E; Racca, P; Ricardi, U; Skanjeti, A | 1 |
| Bydder, GM; Bydder, M; Cornell, M; Einck, J; Fanta, P; Hoh, CK; Lawson, JD; Liang, Y; Mell, LK; Mundt, AJ; Rose, BS; Saenz, C; Yashar, CM | 1 |
| Lupinacci, RM; Menegaux, F; Simon, JM; Spano, JP | 1 |
| Allen, JN; Blaszkowsky, LS; Drapek, LC; Hong, TS; Jee, KW; Lee, LK; Murphy, JE; Niemierko, A; Rose, BS; Wang, Y; Wo, JY | 1 |
| Behrendt, FF; Eble, MJ; Heinzel, A; Mohammadkhani Shali, S; Mottaghy, FM; Schmitt, V; Verburg, FA; Winz, OH | 1 |
11 other study(ies) available for fluorodeoxyglucose f18 and mitomycin
| Article | Year |
|---|---|
Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Deoxyglucose; Doxorubicin; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Stomach Neoplasms; Time Factors; Tomography, Emission-Computed; Transplantation, Heterologous | 1997 |
[Usefulness of F-18-fluorodeoxyglucose positron emission tomography for evaluating the efficacy of transient hepatic arterial chemoembolization for liver metastases of rectal cancer--a case report].
Topics: Chemoembolization, Therapeutic; Cholecystectomy; Doxorubicin; Fluorodeoxyglucose F18; Hepatectomy; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Mitomycin; Positron-Emission Tomography; Rectal Neoplasms; Starch | 2004 |
Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Neoplasms, Experimental; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Vinblastine | 2004 |
F-18 FDG PET-CT findings of intraperitoneal carbon particles-induced granulomas mimicking peritoneal carcinomatosis.
Topics: Adult; Carbon; Diagnosis, Differential; Extravasation of Diagnostic and Therapeutic Materials; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Male; Middle Aged; Mitomycin; Neoplasm, Residual; Particle Size; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorodeoxyglucose F18; Fluorouracil; Humans; Mitomycin; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Statistics, Nonparametric | 2009 |
Chemoradiotherapy in the management of primary squamous-cell carcinoma of the rectum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Mitomycin; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy, Adjuvant; Rectal Neoplasms; Retrospective Studies; Treatment Outcome | 2011 |
Role of positron emission tomography-computed tomography in the management of anal cancer.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Digital Rectal Examination; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proctoscopy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2012 |
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cisplatin; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Multimodal Imaging; Organ Sparing Treatments; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
Aggressive strategy for the treatment of synchronous metastatic anal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mitomycin; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Tomography, X-Ray Computed | 2013 |
Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.
Topics: Adult; Aged; Antineoplastic Agents; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cohort Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Linear Models; Male; Middle Aged; Mitomycin; Neutropenia; Pelvic Bones; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2016 |
Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Forecasting; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden | 2016 |